ID

33195

Description

Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans; ODM derived from: https://clinicaltrials.gov/show/NCT01165190

Link

https://clinicaltrials.gov/show/NCT01165190

Keywords

  1. 11/30/18 11/30/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 30, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type II Diabetes Mellitus NCT01165190

Eligibility Type II Diabetes Mellitus NCT01165190

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent.
Description

Able to communicate Research Personnel | Informed Consent

Data type

boolean

Alias
UMLS CUI [1,1]
C2364293
UMLS CUI [1,2]
C0035173
UMLS CUI [2]
C0021430
2. subjects may be of either sex with age as described in each protocol. female subjects must be non-lactating and will be eligible only if they have a negative pregnancy test throughout the study period.
Description

Age Study Protocol | Gender Breast Feeding Absent | Gender Pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C2348563
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0006147
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0427780
3. subjects must range in age from 18-65.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
4. subjects must have the following laboratory values:
Description

Laboratory Results

Data type

boolean

Alias
UMLS CUI [1]
C1254595
2-hour ogtt plasma glucose 140-250 mg/dl
Description

Plasma Glucose Measurement OGTT

Data type

boolean

Alias
UMLS CUI [1,1]
C0202042
UMLS CUI [1,2]
C0029161
hematocrit ≥ 35 vol%
Description

Hematocrit level

Data type

boolean

Alias
UMLS CUI [1]
C0518014
serum creatinine ≤ 1.6 mg/dl
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
ast (sgot) < 2.5 times upper limit of normal
Description

Aspartate aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201899
alt (sgpt) < 2.5 times upper limit of normal
Description

Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201836
pt, ptt within the normal range
Description

Prothrombin time normal | Partial Thromboplastin Time measurement Normal

Data type

boolean

Alias
UMLS CUI [1]
C0580551
UMLS CUI [2,1]
C0030605
UMLS CUI [2,2]
C0205307
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. subjects must not be receiving any medications with known effects on glucose tolerance unless the subject has been on stable dose of such agents for the past three months before entry into the study. subjects taking systemic glucocorticoids will be excluded. subjects may be taking a stable dose of estrogens or other hormonal replacement therapy, if the subject has been on these agents for the prior three months.
Description

Pharmaceutical Preparations Effect Glucose tolerance | Glucocorticoids, Systemic | Estrogens Dose Stable allowed | Hormone replacement therapy Dose Stable allowed

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1280500
UMLS CUI [1,3]
C0178665
UMLS CUI [2]
C3540777
UMLS CUI [3,1]
C0014939
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [3,4]
C0683607
UMLS CUI [4,1]
C0282402
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
UMLS CUI [4,4]
C0683607
2. history of clinically significant heart disease, including ischemic heart disease (new york heart classification greater than grade ii; more than non-specific st-t wave changes on the ekg) and congestive heart failure
Description

Heart Disease | Myocardial Ischemia New York Heart Association Classification | Myocardial Ischemia More Than ECG Nonspecific ST-T change | Congestive heart failure

Data type

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2,1]
C0151744
UMLS CUI [2,2]
C1275491
UMLS CUI [3,1]
C0151744
UMLS CUI [3,2]
C0439093
UMLS CUI [3,3]
C1112720
UMLS CUI [4]
C0018802
3. history of peripheral vascular disease (history of claudication)
Description

Peripheral Vascular Disease | Claudication

Data type

boolean

Alias
UMLS CUI [1]
C0085096
UMLS CUI [2]
C1456822
4. history of pulmonary disease (dyspnea on exertion of one flight or less; abnormal breath sounds on auscultation).
Description

Lung disease | Dyspnea on exertion | Abnormal breath sounds Auscultation

Data type

boolean

Alias
UMLS CUI [1]
C0024115
UMLS CUI [2]
C0231807
UMLS CUI [3,1]
C0231856
UMLS CUI [3,2]
C0004339
5. history of peripheral edema
Description

Peripheral edema

Data type

boolean

Alias
UMLS CUI [1]
C0085649
6. uncontrolled hypertension with systolic bp>160 mmhg, diastolic bp>100 mmhg
Description

Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure

Data type

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
7. resting heart rate >100 beats/min
Description

Resting heart rate

Data type

boolean

Alias
UMLS CUI [1]
C1821417
8. autonomic neuropathy
Description

Autonomic neuropathy

Data type

boolean

Alias
UMLS CUI [1]
C0259749
9. heavy alcohol consumption (> 2 drinks/day)
Description

Heavy drinker Alcoholic drinks per day

Data type

boolean

Alias
UMLS CUI [1,1]
C0337678
UMLS CUI [1,2]
C0001967
UMLS CUI [1,3]
C0439505

Similar models

Eligibility Type II Diabetes Mellitus NCT01165190

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Able to communicate Research Personnel | Informed Consent
Item
1. subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent.
boolean
C2364293 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Age Study Protocol | Gender Breast Feeding Absent | Gender Pregnancy test negative
Item
2. subjects may be of either sex with age as described in each protocol. female subjects must be non-lactating and will be eligible only if they have a negative pregnancy test throughout the study period.
boolean
C0001779 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C0006147 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0079399 (UMLS CUI [3,1])
C0427780 (UMLS CUI [3,2])
Age
Item
3. subjects must range in age from 18-65.
boolean
C0001779 (UMLS CUI [1])
Laboratory Results
Item
4. subjects must have the following laboratory values:
boolean
C1254595 (UMLS CUI [1])
Plasma Glucose Measurement OGTT
Item
2-hour ogtt plasma glucose 140-250 mg/dl
boolean
C0202042 (UMLS CUI [1,1])
C0029161 (UMLS CUI [1,2])
Hematocrit level
Item
hematocrit ≥ 35 vol%
boolean
C0518014 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine ≤ 1.6 mg/dl
boolean
C0201976 (UMLS CUI [1])
Aspartate aminotransferase measurement
Item
ast (sgot) < 2.5 times upper limit of normal
boolean
C0201899 (UMLS CUI [1])
Alanine aminotransferase measurement
Item
alt (sgpt) < 2.5 times upper limit of normal
boolean
C0201836 (UMLS CUI [1])
Prothrombin time normal | Partial Thromboplastin Time measurement Normal
Item
pt, ptt within the normal range
boolean
C0580551 (UMLS CUI [1])
C0030605 (UMLS CUI [2,1])
C0205307 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Effect Glucose tolerance | Glucocorticoids, Systemic | Estrogens Dose Stable allowed | Hormone replacement therapy Dose Stable allowed
Item
1. subjects must not be receiving any medications with known effects on glucose tolerance unless the subject has been on stable dose of such agents for the past three months before entry into the study. subjects taking systemic glucocorticoids will be excluded. subjects may be taking a stable dose of estrogens or other hormonal replacement therapy, if the subject has been on these agents for the prior three months.
boolean
C0013227 (UMLS CUI [1,1])
C1280500 (UMLS CUI [1,2])
C0178665 (UMLS CUI [1,3])
C3540777 (UMLS CUI [2])
C0014939 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0683607 (UMLS CUI [3,4])
C0282402 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
C0683607 (UMLS CUI [4,4])
Heart Disease | Myocardial Ischemia New York Heart Association Classification | Myocardial Ischemia More Than ECG Nonspecific ST-T change | Congestive heart failure
Item
2. history of clinically significant heart disease, including ischemic heart disease (new york heart classification greater than grade ii; more than non-specific st-t wave changes on the ekg) and congestive heart failure
boolean
C0018799 (UMLS CUI [1])
C0151744 (UMLS CUI [2,1])
C1275491 (UMLS CUI [2,2])
C0151744 (UMLS CUI [3,1])
C0439093 (UMLS CUI [3,2])
C1112720 (UMLS CUI [3,3])
C0018802 (UMLS CUI [4])
Peripheral Vascular Disease | Claudication
Item
3. history of peripheral vascular disease (history of claudication)
boolean
C0085096 (UMLS CUI [1])
C1456822 (UMLS CUI [2])
Lung disease | Dyspnea on exertion | Abnormal breath sounds Auscultation
Item
4. history of pulmonary disease (dyspnea on exertion of one flight or less; abnormal breath sounds on auscultation).
boolean
C0024115 (UMLS CUI [1])
C0231807 (UMLS CUI [2])
C0231856 (UMLS CUI [3,1])
C0004339 (UMLS CUI [3,2])
Peripheral edema
Item
5. history of peripheral edema
boolean
C0085649 (UMLS CUI [1])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure
Item
6. uncontrolled hypertension with systolic bp>160 mmhg, diastolic bp>100 mmhg
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Resting heart rate
Item
7. resting heart rate >100 beats/min
boolean
C1821417 (UMLS CUI [1])
Autonomic neuropathy
Item
8. autonomic neuropathy
boolean
C0259749 (UMLS CUI [1])
Heavy drinker Alcoholic drinks per day
Item
9. heavy alcohol consumption (> 2 drinks/day)
boolean
C0337678 (UMLS CUI [1,1])
C0001967 (UMLS CUI [1,2])
C0439505 (UMLS CUI [1,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial